DENVER, CO--(NewMediaWire - Jan 18, 2017) - Ubiquitech Software
Corp. (OTC PINK: UBQU), with pending name and symbol change to
Endo BioSciences Inc, and its subsidiary HempLife Today™, is
announcing its new CannzALL™ CBD hemp product improvements for 2017
that company data shows will help increase new sales, and sales to
existing customers, as well as maintaining high company standards
of customer satisfaction. New product improvements will be phased
in and available by February 15th.
The Company has carefully looked at sales data from the last 18
months and concluded which CannazALL™ CBD products would be
improved upon, added, or dropped from the www.HempLifeToday.com Website. With these
changes and additions the Company expects to see an immediate and
sustained increase in sales volume. All new products and product
improvements will feature the NanoTech Infusion Process™ announced
last year. The new product line will be...
Refreshing Peppermint Tincture: This is
the company's number one product and is responsible for 65% of all
new sales. Easy to dose with a convenient dropper this product also
gets the highest reorder rate. Because this is the only flavored
product the company offers for ingestion, a new and more refreshing
all natural peppermint taste that has been tested among uses was
found to be considerably more pleasant to take. Therefore the
Company expects this product to see an increase in first time, and
repeat, sales. This product will be available in 250mg and 500mg
one ounce bottles with dropper.
Potent Concentrated Oil: This pure oil
will stay in the oral syringe but more plant terpines, and
beneficial Chlorophyll will be added for a superior "entourage
effect" Available in 300mg and 800mg versions.
Infused GelCaps: This product will now
feature a 100% vegan outer casing that is clear and allows the CBD
oil to be seen within. In addition, it will be infused with a
higher concentrate of additional hemp plant materials that are
showing to be beneficial for human health. GelCaps will be vailable
in 25mg form at 30 per jar.
Mixable Powder: The Company is moving from
a Soluble Powder to a Mixable Powder that will blend better with
shakes, smoothies, and food. This is a superior product than
previously offered as it has more popular uses that customers have
inquired about. This product will be available in a 1,000mg
jar.
Topical Skin Salve: No changes for 2017.
This very popular product will stay available in 2oz jar with 400mg
of CBD.
Island Punch Vape Oil: No changes for
2017. This very popular product will stay available in 5ml vial
with 60mg of CBD.
New dabbing "Honey": This new and exciting
dabbing product is used with a wax vape (Also available on the site
@ www.hemplifetoday.comand is over 90% pure CBD.
It will come in a syringe to easily dab onto a vape. This product
will be available in a 1gram size with over 800mg of pure cbd per
gram.
Dabbing Shatter: This product was never
introduced to the Site but was offered in limited promotions. This
product proved too expensive to market on a wider scale and has a
very limited customer appeal. This product will be reevaluated in
2017.
Dabbing Crumble: This product has also
shown to be expensive to manufacture and has limited customer
appeal. This product will be replaced by another more popular vape
product with a larger universe of consumers.
New Products: New products are in the
works and will be announced as they come to fruition. New products
to be announced could include... New flavored Vape Juices, CBD
Gummies, new flavored Tinctures, and additional concentrates, as
well as some items that cannot be made public yet.
Summary: The Company believes that this
new line of product improvements will consistently build new sales
and keep customers ordering more CannazALL™ CBD products. Al
CannazALL™ CBD products are derived from hemp and comply with the
2014 Farm Bill.
"We put a lot of effort into our products and are always
looking at what works best for our customers," said Luke
Dreyer, COO. "We are in an industry where we are learning
on an almost quarterly basis as more and more research and data
comes in. To stay on top of this business means regular analysis
and reformulating of products, but we are set up to do this and it
keeps our company growing."
"With all that we have learned and achieved in 2016 we
really look at 2017 as our first solid year for consistent and
substantial growth," adds James Ballas CEO, "and
we've hit the ground running at a much higher capacity right from
the start. This should make first quarter our best ever, and
everything we do is to continue creating growth throughout the
year."
About Ubiquitech (HempLife Today™)
Ubiquitech Software Corp, through its subsidiaries is a dynamic
multi-media, multi-faceted corporation utilizing state-of-the-art
global internet marketing, Direct Response (DRTV) Television,
Radio, and traditional marketing, to drive traffic to the new and
emerging multi-billion dollar industries like its subsidiary
HempLifeToday.com™
HempLifeToday™ focuses on the exciting and dynamic new thinking
in the world today that recognizes the important health and life
enriching enhancement that CBD Oil from the Hemp plant can bring.
Through its network of quality USA growers HempLifeToday.com™ has
developed multiple and proprietary CannazALL™ CBD oil products that
include; its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin
Salve, Wax Crumble, and e-liquid, all offered @ www.HempLifeToday.com
This press release contains forward-looking statements. Words
such as "expects", "intends'', "believes'', and similar expressions
reflecting something other than historical fact are intended to
identify forward-looking statements, but are not the exclusive
means of identifying such statements. These forward-looking
statements involve a number of risks and uncertainties, including
the timely development and market acceptance of products and
technologies, the ability to secure additional sources of finance,
the ability to reduce operating expenses, and other factors
described in the Company's filings with the OTC Markets Group. The
actual results that the Company achieves may differ materially from
any forward-looking statement due to such risks and uncertainties.
The Company undertakes no obligation to revise or update any
forward-looking statements in order to reflect events or
circumstances that may arise after the date of this release.